Breast cancer spreads to other organs in the body according to certain specific patterns. This has been shown by a team of researchers from Karolinska Institutet and KTH in Sweden and the University of Helsinki in Finland who have mapped breast cancer’s spread routes in patients by studying the cancer cells’ DNA. The study is published in The Journal of Clinical Investigation.
New TSRI study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens
Scientists from The Scripps Research Institute (TSRI) have discovered that two estrogen-mimicking compounds found in many foods appear to potently reverse the effects of palbociclib/letrozole, a popular drug combination for treating breast cancer.
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research presented at EHRA EUROPACE - CARDIOSTIM 2017.1
A new study from the ABCSG (Austrian Breast & Colorectal Cancer Study Group) indicates that women suffering from metastasised breast cancer do not benefit from surgery performed prior to drug treatment. This could cause a paradigm shift in treatment of the disease.
Mothers protect their babies and teach them habits to stay healthy and safe as they grow. A new UCLA-led study shows that beneficial bacteria from mothers do much the same thing.
Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to date, presented at ECC2017. Dutch researchers report that considerably superior survival, both specific to breast cancer and from any cause of death, was found among certain groups of patients who had had BCT.